| Year |
Citation |
Score |
| 2023 |
Chen L, Fu L, Sun J, Huang Z, Fang M, Zinkle A, Liu X, Lu J, Pan Z, Wang Y, Liang G, Li X, Chen G, Mohammadi M. Structural basis for FGF hormone signalling. Nature. PMID 37286607 DOI: 10.1038/s41586-023-06155-9 |
0.473 |
|
| 2023 |
Besch A, Marsiglia WM, Mohammadi M, Zhang Y, Traaseth NJ. Gatekeeper mutations activate FGF receptor tyrosine kinases by destabilizing the autoinhibited state. Proceedings of the National Academy of Sciences of the United States of America. 120: e2213090120. PMID 36791110 DOI: 10.1073/pnas.2213090120 |
0.313 |
|
| 2021 |
Ying L, Wang L, Guo K, Hou Y, Li N, Wang S, Liu X, Zhao Q, Zhou J, Zhao L, Niu J, Chen C, Song L, Hou S, Kong L, ... ... Mohammadi M, et al. Paracrine FGFs target skeletal muscle to exert potent anti-hyperglycemic effects. Nature Communications. 12: 7256. PMID 34907199 DOI: 10.1038/s41467-021-27584-y |
0.399 |
|
| 2020 |
Niu J, Zhao J, Wu J, Qiao G, Gu J, Zhou C, Li Q, Ying L, Wang D, Lin H, Li X, Mohammadi M, Huang Z. Curtailing FGF19's mitogenicity by suppressing its receptor dimerization ability. Proceedings of the National Academy of Sciences of the United States of America. PMID 33144503 DOI: 10.1073/pnas.2010984117 |
0.39 |
|
| 2020 |
Xie Y, Zinkle A, Chen L, Mohammadi M. Fibroblast growth factor signalling in osteoarthritis and cartilage repair. Nature Reviews. Rheumatology. PMID 32807927 DOI: 10.1038/S41584-020-0469-2 |
0.473 |
|
| 2020 |
Agoro R, Park MY, Le Henaff C, Jankauskas S, Gaias A, Chen G, Mohammadi M, Sitara D. C-FGF23 peptide alleviates hypoferremia during acute inflammation. Haematologica. PMID 32193252 DOI: 10.3324/Haematol.2019.237040 |
0.349 |
|
| 2020 |
Shamsi F, Xue R, Huang TL, Lundh M, Liu Y, Leiria LO, Lynes MD, Kempf E, Wang CH, Sugimoto S, Nigro P, Landgraf K, Schulz T, Li Y, Emanuelli B, ... ... Mohammadi M, et al. FGF6 and FGF9 regulate UCP1 expression independent of brown adipogenesis. Nature Communications. 11: 1421. PMID 32184391 DOI: 10.1038/S41467-020-15055-9 |
0.483 |
|
| 2020 |
Chen L, Marsiglia WM, Chen H, Katigbak J, Erdjument-Bromage H, Kemble DJ, Fu L, Ma J, Sun G, Zhang Y, Liang G, Neubert TA, Li X, Traaseth NJ, Mohammadi M. Molecular basis for receptor tyrosine kinase A-loop tyrosine transphosphorylation. Nature Chemical Biology. PMID 31959966 DOI: 10.1038/S41589-019-0455-7 |
0.406 |
|
| 2020 |
Besch A, Marsiglia W, Mohammadi M, Zhang Y, Traaseth N. Elucidating the Activating Mechanism of Gatekeeper Mutations on Receptor Tyrosine Kinases Biophysical Journal. 118: 53a. DOI: 10.1016/J.Bpj.2019.11.468 |
0.395 |
|
| 2019 |
Zhao L, Niu J, Lin H, Zhao J, Liu Y, Song Z, Xiang C, Wang X, Yang Y, Li X, Mohammadi M, Huang Z. Paracrine-endocrine FGF chimeras as potent therapeutics for metabolic diseases. Ebiomedicine. PMID 31631034 DOI: 10.1016/J.Ebiom.2019.09.052 |
0.527 |
|
| 2019 |
He Q, Shumate LT, Matthias J, Aydin C, Wein MN, Spatz JM, Goetz R, Mohammadi M, Plagge A, Divieti Pajevic P, Bastepe M. A G protein-coupled, IP3/protein kinase C pathway controlling the synthesis of phosphaturic hormone FGF23. Jci Insight. 4. PMID 31484825 DOI: 10.1172/Jci.Insight.125007 |
0.437 |
|
| 2019 |
Marsiglia WM, Katigbak J, Zheng S, Mohammadi M, Zhang Y, Traaseth NJ. A Conserved Allosteric Pathway in Tyrosine Kinase Regulation. Structure (London, England : 1993). PMID 31204250 DOI: 10.1016/J.Str.2019.05.002 |
0.392 |
|
| 2019 |
Zinkle A, Mohammadi M. Structural Biology of the FGF7 Subfamily. Frontiers in Genetics. 10: 102. PMID 30809251 DOI: 10.3389/Fgene.2019.00102 |
0.601 |
|
| 2018 |
Tassi E, Garman KA, Schmidt MO, Ma X, Kabbara KW, Uren A, Tomita Y, Goetz R, Mohammadi M, Wilcox CS, Riegel AT, Carlstrom M, Wellstein A. Fibroblast Growth Factor Binding Protein 3 (FGFBP3) impacts carbohydrate and lipid metabolism. Scientific Reports. 8: 15973. PMID 30374109 DOI: 10.1038/S41598-018-34238-5 |
0.357 |
|
| 2018 |
Zinkle A, Mohammadi M. A threshold model for receptor tyrosine kinase signaling specificity and cell fate determination. F1000research. 7. PMID 29983915 DOI: 10.12688/F1000Research.14143.1 |
0.405 |
|
| 2018 |
Agoro R, Montagna A, Goetz R, Aligbe O, Singh G, Coe LM, Mohammadi M, Rivella S, Sitara D. Inhibition of fibroblast growth factor 23 (FGF23) signaling rescues renal anemia. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. fj201700667R. PMID 29481308 DOI: 10.1096/Fj.201700667R |
0.369 |
|
| 2018 |
Chen G, Liu Y, Goetz R, Fu L, Jayaraman S, Hu MC, Moe OW, Liang G, Li X, Mohammadi M. α-Klotho is a non-enzymatic molecular scaffold for FGF23 hormone signalling. Nature. PMID 29342138 DOI: 10.1038/Nature25451 |
0.516 |
|
| 2017 |
Huang C, Liu Y, Beenken A, Jiang L, Gao X, Huang Z, Hsu A, Gross GJ, Wang YG, Mohammadi M, Schultz JEJ. A novel fibroblast growth factor-1 ligand with reduced heparin binding protects the heart against ischemia-reperfusion injury in the presence of heparin co-administration. Cardiovascular Research. PMID 29016740 DOI: 10.1093/Cvr/Cvx165 |
0.77 |
|
| 2017 |
Huang Z, Tan Y, Gu J, Liu Y, Song L, Niu J, Zhao L, Srinivasan L, Lin Q, Deng J, Li Y, Conklin DJ, Neubert TA, Cai L, Li X, ... Mohammadi M, et al. Uncoupling the Mitogenic and Metabolic Functions of FGF1 by Tuning FGF1-FGF Receptor Dimer Stability. Cell Reports. 20: 1717-1728. PMID 28813681 DOI: 10.1016/J.Celrep.2017.06.063 |
0.533 |
|
| 2017 |
Liu Y, Ma J, Beenken A, Srinivasan L, Eliseenkova AV, Mohammadi M. Regulation of Receptor Binding Specificity of FGF9 by an Autoinhibitory Homodimerization. Structure (London, England : 1993). PMID 28757146 DOI: 10.1016/J.Str.2017.06.016 |
0.817 |
|
| 2017 |
Xu C, Messina A, Somm E, Miraoui H, Kinnunen T, Acierno J, Niederländer NJ, Bouilly J, Dwyer AA, Sidis Y, Cassatella D, Sykiotis GP, Quinton R, De Geyter C, Dirlewanger M, ... ... Mohammadi M, et al. KLB, encoding β-Klotho, is mutated in patients with congenital hypogonadotropic hypogonadism. Embo Molecular Medicine. PMID 28754744 DOI: 10.15252/Emmm.201607376 |
0.473 |
|
| 2017 |
Liang G, Song L, Chen Z, Qian Y, Xie J, Zhao L, Lin Q, Zhu G, Tan Y, Li X, Mohammadi M, Huang Z. Fibroblast growth factor 1 ameliorates diabetic nephropathy by an anti-inflammatory mechanism. Kidney International. PMID 28750927 DOI: 10.1016/J.Kint.2017.05.013 |
0.306 |
|
| 2017 |
Johnson K, Levine K, Sergi J, Chamoun J, Roach R, Vekich J, Favis M, Horn M, Cao X, Miller B, Snyder W, Aivazian D, Reagan W, Berryman E, Colangelo J, ... ... Mohammadi M, et al. Therapeutic Effects of FGF23 c-tail Fc in a murine pre-clinical model of X-linked hypophosphatemia via the selective modulation of phosphate reabsorption. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. PMID 28600887 DOI: 10.1002/Jbmr.3197 |
0.434 |
|
| 2017 |
Somm E, Henry H, Bruce SJ, Aeby S, Rosikiewicz M, Sykiotis GP, Asrih M, Jornayvaz FR, Denechaud PD, Albrecht U, Mohammadi M, Dwyer A, Acierno JS, Schoonjans K, Fajas L, et al. β-Klotho deficiency protects against obesity through a crosstalk between liver, microbiota, and brown adipose tissue. Jci Insight. 2. PMID 28422755 DOI: 10.1172/Jci.Insight.91809 |
0.346 |
|
| 2017 |
Xu C, Lang-Muritano M, Phan-Hug F, Dwyer AA, Sykiotis GP, Cassatella D, Acierno J, Mohammadi M, Pitteloud N. Genetic testing facilitates prepubertal diagnosis of congenital hypogonadotropic hypogonadism. Clinical Genetics. PMID 28195315 DOI: 10.1111/Cge.12996 |
0.389 |
|
| 2017 |
Chen H, Marsiglia WM, Cho MK, Huang Z, Deng J, Blais SP, Gai W, Bhattacharya S, Neubert TA, Traaseth NJ, Mohammadi M. Elucidation of a four-site allosteric network in fibroblast growth factor receptor tyrosine kinases. Elife. 6. PMID 28166054 DOI: 10.7554/Elife.21137 |
0.414 |
|
| 2017 |
Marsiglia WM, Chen H, Cho M, Mohammadi M, Traaseth NJ. Characterization of Disease Causing Mutations Associated with FGF Receptor Tyrosine Kinases using NMR Spectroscopy Biophysical Journal. 112: 64a. DOI: 10.1016/J.Bpj.2016.11.383 |
0.44 |
|
| 2016 |
Liu Y, Zhao C, Xiao J, Liu L, Zhang M, Wang C, Wu G, Zheng MH, Xu LM, Chen YP, Mohammadi M, Chen SY, Cave M, McClain C, Li X, et al. Fibroblast growth factor 21 deficiency exacerbates chronic alcohol-induced hepatic steatosis and injury. Scientific Reports. 6: 31026. PMID 27498701 DOI: 10.1038/Srep31026 |
0.315 |
|
| 2016 |
Fresco VM, Kern CB, Mohammadi M, Twal WO. Fibulin-1 Binds to Fibroblast Growth Factor 8 with High Affinity: Effects on Embryo Survival. The Journal of Biological Chemistry. PMID 27402846 DOI: 10.1074/Jbc.M115.702761 |
0.508 |
|
| 2016 |
Chen H, Marsiglia WM, Cho M, Huang Z, Deng J, Blais SP, Gai W, Bhattacharya S, Neubert TA, Traaseth NJ, Mohammadi M. Author response: Elucidation of a four-site allosteric network in fibroblast growth factor receptor tyrosine kinases Elife. DOI: 10.7554/Elife.21137.022 |
0.376 |
|
| 2016 |
Marsiglia W, Chen H, Cho M, Mohammadi M, Traaseth NJ. NMR Experiments on Wild-Type and Mutant Fibroblast Growth Factor Receptor Kinases Reveal Conformational Dynamics Associated with Enzyme Activation Biophysical Journal. 110: 220a. DOI: 10.1016/J.Bpj.2015.11.1222 |
0.406 |
|
| 2015 |
Huang Z, Marsiglia WM, Basu Roy U, Rahimi N, Ilghari D, Wang H, Chen H, Gai W, Blais S, Neubert TA, Mansukhani A, Traaseth NJ, Li X, Mohammadi M. Two FGF Receptor Kinase Molecules Act in Concert to Recruit and Transphosphorylate Phospholipase Cγ. Molecular Cell. PMID 26687682 DOI: 10.1016/J.Molcel.2015.11.010 |
0.393 |
|
| 2015 |
Suh JM, Jonker JW, Ahmadian M, Goetz R, Lackey D, Osborn O, Huang Z, Liu W, Yoshihara E, van Dijk TH, Havinga R, Fan W, Yin YQ, Yu RT, Liddle C, ... ... Mohammadi M, et al. Corrigendum: Endocrinization of FGF1 produces a neomorphic and potent insulin sensitizer. Nature. 520: 388. PMID 25739500 DOI: 10.1038/Nature14304 |
0.351 |
|
| 2015 |
Huang Z, Tan L, Wang H, Liu Y, Blais S, Deng J, Neubert TA, Gray NS, Li X, Mohammadi M. DFG-out mode of inhibition by an irreversible type-1 inhibitor capable of overcoming gate-keeper mutations in FGF receptors. Acs Chemical Biology. 10: 299-309. PMID 25317566 DOI: 10.1021/Cb500674S |
0.423 |
|
| 2014 |
Villanueva C, Jacobson-Dickman E, Xu C, Manouvrier S, Dwyer AA, Sykiotis GP, Beenken A, Liu Y, Tommiska J, Hu Y, Tiosano D, Gerard M, Leger J, Drouin-Garraud V, Lefebvre H, ... ... Mohammadi M, et al. Congenital hypogonadotropic hypogonadism with split hand/foot malformation: a clinical entity with a high frequency of FGFR1 mutations. Genetics in Medicine : Official Journal of the American College of Medical Genetics. PMID 25394172 DOI: 10.1038/Gim.2014.166 |
0.708 |
|
| 2014 |
Tan L, Wang J, Tanizaki J, Huang Z, Aref AR, Rusan M, Zhu SJ, Zhang Y, Ercan D, Liao RG, Capelletti M, Zhou W, Hur W, Kim N, Sim T, ... ... Mohammadi M, et al. Development of covalent inhibitors that can overcome resistance to first-generation FGFR kinase inhibitors. Proceedings of the National Academy of Sciences of the United States of America. 111: E4869-77. PMID 25349422 DOI: 10.1073/Pnas.1403438111 |
0.41 |
|
| 2014 |
Suh JM, Jonker JW, Ahmadian M, Goetz R, Lackey D, Osborn O, Huang Z, Liu W, Yoshihara E, van Dijk TH, Havinga R, Fan W, Yin YQ, Yu RT, Liddle C, ... ... Mohammadi M, et al. Endocrinization of FGF1 produces a neomorphic and potent insulin sensitizer. Nature. 513: 436-9. PMID 25043058 DOI: 10.1038/Nature13540 |
0.318 |
|
| 2014 |
Markan KR, Naber MC, Ameka MK, Anderegg MD, Mangelsdorf DJ, Kliewer SA, Mohammadi M, Potthoff MJ. Circulating FGF21 is liver derived and enhances glucose uptake during refeeding and overfeeding. Diabetes. 63: 4057-63. PMID 25008183 DOI: 10.2337/Db14-0595 |
0.337 |
|
| 2014 |
Fan J, Shan C, Kang HB, Elf S, Xie J, Tucker M, Gu TL, Aguiar M, Lonning S, Chen H, Mohammadi M, Britton LM, Garcia BA, AleÄković M, Kang Y, et al. Tyr phosphorylation of PDP1 toggles recruitment between ACAT1 and SIRT3 to regulate the pyruvate dehydrogenase complex. Molecular Cell. 53: 534-48. PMID 24486017 DOI: 10.1016/J.Molcel.2013.12.026 |
0.316 |
|
| 2014 |
Andrukhova O, Smorodchenko A, Egerbacher M, Streicher C, Zeitz U, Goetz R, Shalhoub V, Mohammadi M, Pohl EE, Lanske B, Erben RG. FGF23 promotes renal calcium reabsorption through the TRPV5 channel. The Embo Journal. 33: 229-46. PMID 24434184 DOI: 10.1002/Embj.201284188 |
0.385 |
|
| 2013 |
Olauson H, Lindberg K, Amin R, Sato T, Jia T, Goetz R, Mohammadi M, Andersson G, Lanske B, Larsson TE. Parathyroid-specific deletion of Klotho unravels a novel calcineurin-dependent FGF23 signaling pathway that regulates PTH secretion. Plos Genetics. 9: e1003975. PMID 24348262 DOI: 10.1371/Journal.Pgen.1003975 |
0.424 |
|
| 2013 |
Huang Z, Chen H, Blais S, Neubert TA, Li X, Mohammadi M. Structural mimicry of a-loop tyrosine phosphorylation by a pathogenic FGF receptor 3 mutation. Structure (London, England : 1993). 21: 1889-96. PMID 23972473 DOI: 10.1016/J.Str.2013.07.017 |
0.405 |
|
| 2013 |
Byron SA, Chen H, Wortmann A, Loch D, Gartside MG, Dehkhoda F, Blais SP, Neubert TA, Mohammadi M, Pollock PM. The N550K/H mutations in FGFR2 confer differential resistance to PD173074, dovitinib, and ponatinib ATP-competitive inhibitors. Neoplasia (New York, N.Y.). 15: 975-88. PMID 23908597 DOI: 10.1593/Neo.121106 |
0.371 |
|
| 2013 |
Chen H, Huang Z, Dutta K, Blais S, Neubert TA, Li X, Cowburn D, Traaseth NJ, Mohammadi M. Cracking the molecular origin of intrinsic tyrosine kinase activity through analysis of pathogenic gain-of-function mutations. Cell Reports. 4: 376-84. PMID 23871672 DOI: 10.1016/J.Celrep.2013.06.025 |
0.592 |
|
| 2013 |
Uchihashi K, Nakatani T, Goetz R, Mohammadi M, He X, Razzaque MS. FGF23-induced hypophosphatemia persists in Hyp mice deficient in the WNT coreceptor Lrp6. Contributions to Nephrology. 180: 124-37. PMID 23652555 DOI: 10.1159/000346792 |
0.402 |
|
| 2013 |
Miraoui H, Dwyer AA, Sykiotis GP, Plummer L, Chung W, Feng B, Beenken A, Clarke J, Pers TH, Dworzynski P, Keefe K, Niedziela M, Raivio T, Crowley WF, Seminara SB, ... ... Mohammadi M, et al. Mutations in FGF17, IL17RD, DUSP6, SPRY4, and FLRT3 are identified in individuals with congenital hypogonadotropic hypogonadism. American Journal of Human Genetics. 92: 725-43. PMID 23643382 DOI: 10.1016/J.Ajhg.2013.04.008 |
0.766 |
|
| 2013 |
Lindberg K, Olauson H, Amin R, Ponnusamy A, Goetz R, Taylor RF, Mohammadi M, Canfield A, Kublickiene K, Larsson TE. Arterial klotho expression and FGF23 effects on vascular calcification and function. Plos One. 8: e60658. PMID 23577141 DOI: 10.1371/Journal.Pone.0060658 |
0.377 |
|
| 2013 |
Goetz R, Mohammadi M. Exploring mechanisms of FGF signalling through the lens of structural biology. Nature Reviews. Molecular Cell Biology. 14: 166-80. PMID 23403721 DOI: 10.1038/Nrm3528 |
0.538 |
|
| 2012 |
Belov AA, Mohammadi M. Grb2, a double-edged sword of receptor tyrosine kinase signaling. Science Signaling. 5: pe49. PMID 23131845 DOI: 10.1126/Scisignal.2003576 |
0.391 |
|
| 2012 |
Goetz R, Ohnishi M, Kir S, Kurosu H, Wang L, Pastor J, Ma J, Gai W, Kuro-o M, Razzaque MS, Mohammadi M. Conversion of a paracrine fibroblast growth factor into an endocrine fibroblast growth factor. The Journal of Biological Chemistry. 287: 29134-46. PMID 22733815 DOI: 10.1074/Jbc.M112.342980 |
0.57 |
|
| 2012 |
Andrukhova O, Zeitz U, Goetz R, Mohammadi M, Lanske B, Erben RG. FGF23 acts directly on renal proximal tubules to induce phosphaturia through activation of the ERK1/2-SGK1 signaling pathway. Bone. 51: 621-8. PMID 22647968 DOI: 10.1016/J.Bone.2012.05.015 |
0.459 |
|
| 2012 |
Goetz R, Ohnishi M, Ding X, Kurosu H, Wang L, Akiyoshi J, Ma J, Gai W, Sidis Y, Pitteloud N, Kuro-O M, Razzaque MS, Mohammadi M. Klotho coreceptors inhibit signaling by paracrine fibroblast growth factor 8 subfamily ligands. Molecular and Cellular Biology. 32: 1944-54. PMID 22451487 DOI: 10.1128/Mcb.06603-11 |
0.593 |
|
| 2012 |
Beenken A, Mohammadi M. The structural biology of the FGF19 subfamily. Advances in Experimental Medicine and Biology. 728: 1-24. PMID 22396159 DOI: 10.1007/978-1-4614-0887-1_1 |
0.828 |
|
| 2012 |
Wei W, Dutchak PA, Wang X, Ding X, Bookout AL, Goetz R, Mohammadi M, Gerard RD, Dechow PC, Mangelsdorf DJ, Kliewer SA, Wan Y. Fibroblast growth factor 21 promotes bone loss by potentiating the effects of peroxisome proliferator-activated receptor γ Proceedings of the National Academy of Sciences of the United States of America. 109: 3143-3148. PMID 22315431 DOI: 10.1073/Pnas.1200797109 |
0.392 |
|
| 2012 |
Kalinina J, Dutta K, Ilghari D, Beenken A, Goetz R, Eliseenkova AV, Cowburn D, Mohammadi M. The alternatively spliced acid box region plays a key role in FGF receptor autoinhibition. Structure (London, England : 1993). 20: 77-88. PMID 22244757 DOI: 10.1016/J.Str.2011.10.022 |
0.808 |
|
| 2012 |
Beenken A, Eliseenkova AV, Ibrahimi OA, Olsen SK, Mohammadi M. Plasticity in interactions of fibroblast growth factor 1 (FGF1) N terminus with FGF receptors underlies promiscuity of FGF1. The Journal of Biological Chemistry. 287: 3067-78. PMID 22057274 DOI: 10.1074/Jbc.M111.275891 |
0.842 |
|
| 2011 |
Wang H, Venkatesh M, Li H, Goetz R, Mukherjee S, Biswas A, Zhu L, Kaubisch A, Wang L, Pullman J, Whitney K, Kuro-o M, Roig AI, Shay JW, Mohammadi M, et al. Pregnane X receptor activation induces FGF19-dependent tumor aggressiveness in humans and mice. The Journal of Clinical Investigation. 121: 3220-32. PMID 21747170 DOI: 10.1172/Jci41514 |
0.394 |
|
| 2011 |
Gattineni J, Twombley K, Goetz R, Mohammadi M, Baum M. Regulation of serum 1,25(OH)2 vitamin D3 levels by fibroblast growth factor 23 is mediated by FGF receptors 3 and 4. American Journal of Physiology. Renal Physiology. 301: F371-7. PMID 21561999 DOI: 10.1152/Ajprenal.00740.2010 |
0.394 |
|
| 2011 |
Beenken A, Mohammadi M. The molecular bases for FGF receptor activation in craniosynostosis and dwarfism syndromes Monographs in Human Genetics. 19: 45-57. DOI: 10.1159/000318837 |
0.789 |
|
| 2011 |
Byron SA, Chen H, Mohammadi M, Pollock PM. Abstract 4733: Activating FGFR2 kinase domain mutations provide resistance to dovitinib (TKI258) Cancer Research. 71: 4733-4733. DOI: 10.1158/1538-7445.Am2011-4733 |
0.421 |
|
| 2010 |
Fon Tacer K, Bookout AL, Ding X, Kurosu H, John GB, Wang L, Goetz R, Mohammadi M, Kuro-o M, Mangelsdorf DJ, Kliewer SA. Research resource: Comprehensive expression atlas of the fibroblast growth factor system in adult mouse. Molecular Endocrinology (Baltimore, Md.). 24: 2050-64. PMID 20667984 DOI: 10.1210/Me.2010-0142 |
0.468 |
|
| 2010 |
Saxena K, Schieborr U, Anderka O, Duchardt-Ferner E, Elshorst B, Gande SL, Janzon J, Kudlinzki D, Sreeramulu S, Dreyer MK, Wendt KU, Herbert C, Duchaussoy P, Bianciotto M, Driguez PA, ... ... Mohammadi M, et al. Influence of heparin mimetics on assembly of the FGF.FGFR4 signaling complex. The Journal of Biological Chemistry. 285: 26628-40. PMID 20547770 DOI: 10.1074/Jbc.M109.095109 |
0.571 |
|
| 2010 |
Trarbach EB, Abreu AP, Silveira LF, Garmes HM, Baptista MT, Teles MG, Costa EM, Mohammadi M, Pitteloud N, Mendonca BB, Latronico AC. Nonsense mutations in FGF8 gene causing different degrees of human gonadotropin-releasing deficiency. The Journal of Clinical Endocrinology and Metabolism. 95: 3491-6. PMID 20463092 DOI: 10.1210/Jc.2010-0176 |
0.51 |
|
| 2010 |
Goetz R, Nakada Y, Hu MC, Kurosu H, Wang L, Nakatani T, Shi M, Eliseenkova AV, Razzaque MS, Moe OW, Kuro-o M, Mohammadi M. Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex formation. Proceedings of the National Academy of Sciences of the United States of America. 107: 407-12. PMID 19966287 DOI: 10.1073/Pnas.0902006107 |
0.489 |
|
| 2009 |
Raivio T, Sidis Y, Plummer L, Chen H, Ma J, Mukherjee A, Jacobson-Dickman E, Quinton R, Van Vliet G, Lavoie H, Hughes VA, Dwyer A, Hayes FJ, Xu S, Sparks S, ... ... Mohammadi M, et al. Frequency of Impaired Fibroblast Growth Factor Receptor 1 Signaling as a Cause of Normosmic Idiopathic Hypogonadotropic Hypogonadism. Endocrine Reviews. 30: 934. PMID 28199515 DOI: 10.1210/edrv.30.7.9981 |
0.388 |
|
| 2009 |
Raivio T, Sidis Y, Plummer L, Chen H, Ma J, Mukherjee A, Jacobson-Dickman E, Quinton R, Van Vliet G, Lavoie H, Hughes VA, Dwyer A, Hayes FJ, Xu S, Sparks S, ... ... Mohammadi M, et al. Impaired fibroblast growth factor receptor 1 signaling as a cause of normosmic idiopathic hypogonadotropic hypogonadism. The Journal of Clinical Endocrinology and Metabolism. 94: 4380-90. PMID 19820032 DOI: 10.1210/Jc.2009-0179 |
0.427 |
|
| 2009 |
Makarenkova HP, Hoffman MP, Beenken A, Eliseenkova AV, Meech R, Tsau C, Patel VN, Lang RA, Mohammadi M. Differential interactions of FGFs with heparan sulfate control gradient formation and branching morphogenesis. Science Signaling. 2: ra55. PMID 19755711 DOI: 10.1126/Scisignal.2000304 |
0.833 |
|
| 2009 |
Zhang F, Zhang Z, Lin X, Beenken A, Eliseenkova AV, Mohammadi M, Linhardt RJ. Compositional analysis of heparin/heparan sulfate interacting with fibroblast growth factor.fibroblast growth factor receptor complexes. Biochemistry. 48: 8379-86. PMID 19591432 DOI: 10.1021/Bi9006379 |
0.809 |
|
| 2009 |
Kalinina J, Byron SA, Makarenkova HP, Olsen SK, Eliseenkova AV, Larochelle WJ, Dhanabal M, Blais S, Ornitz DM, Day LA, Neubert TA, Pollock PM, Mohammadi M. Homodimerization controls the fibroblast growth factor 9 subfamily's receptor binding and heparan sulfate-dependent diffusion in the extracellular matrix. Molecular and Cellular Biology. 29: 4663-78. PMID 19564416 DOI: 10.1128/Mcb.01780-08 |
0.846 |
|
| 2009 |
Chen Y, Mohammadi M, Flanagan JG. Graded levels of FGF protein span the midbrain and can instruct graded induction and repression of neural mapping labels. Neuron. 62: 773-80. PMID 19555646 DOI: 10.1016/J.Neuron.2009.05.023 |
0.326 |
|
| 2009 |
Potthoff MJ, Inagaki T, Satapati S, Ding X, He T, Goetz R, Mohammadi M, Finck BN, Mangelsdorf DJ, Kliewer SA, Burgess SC. FGF21 induces PGC-1alpha and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response. Proceedings of the National Academy of Sciences of the United States of America. 106: 10853-8. PMID 19541642 DOI: 10.1073/Pnas.0904187106 |
0.34 |
|
| 2009 |
Gattineni J, Bates C, Twombley K, Dwarakanath V, Robinson ML, Goetz R, Mohammadi M, Baum M. FGF23 decreases renal NaPi-2a and NaPi-2c expression and induces hypophosphatemia in vivo predominantly via FGF receptor 1. American Journal of Physiology. Renal Physiology. 297: F282-91. PMID 19515808 DOI: 10.1152/Ajprenal.90742.2008 |
0.392 |
|
| 2009 |
Goetz R, Dover K, Laezza F, Shtraizent N, Huang X, Tchetchik D, Eliseenkova AV, Xu CF, Neubert TA, Ornitz DM, Goldfarb M, Mohammadi M. Crystal structure of a fibroblast growth factor homologous factor (FHF) defines a conserved surface on FHFs for binding and modulation of voltage-gated sodium channels. The Journal of Biological Chemistry. 284: 17883-96. PMID 19406745 DOI: 10.1074/Jbc.M109.001842 |
0.367 |
|
| 2009 |
Beenken A, Mohammadi M. The FGF family: biology, pathophysiology and therapy. Nature Reviews. Drug Discovery. 8: 235-53. PMID 19247306 DOI: 10.1038/Nrd2792 |
0.776 |
|
| 2009 |
Gartside MG, Chen H, Ibrahimi OA, Byron SA, Curtis AV, Wellens CL, Bengston A, Yudt LM, Eliseenkova AV, Ma J, Curtin JA, Hyder P, Harper UL, Riedesel E, Mann GJ, ... ... Mohammadi M, et al. Loss-of-function fibroblast growth factor receptor-2 mutations in melanoma. Molecular Cancer Research : McR. 7: 41-54. PMID 19147536 DOI: 10.1158/1541-7786.Mcr-08-0021 |
0.727 |
|
| 2009 |
Nakatani T, Sarraj B, Ohnishi M, Densmore MJ, Taguchi T, Goetz R, Mohammadi M, Lanske B, Razzaque MS. In vivo genetic evidence for klotho-dependent, fibroblast growth factor 23 (Fgf23) -mediated regulation of systemic phosphate homeostasis. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 23: 433-41. PMID 18835926 DOI: 10.1096/Fj.08-114397 |
0.429 |
|
| 2008 |
Chen H, Xu CF, Ma J, Eliseenkova AV, Li W, Pollock PM, Pitteloud N, Miller WT, Neubert TA, Mohammadi M. A crystallographic snapshot of tyrosine trans-phosphorylation in action. Proceedings of the National Academy of Sciences of the United States of America. 105: 19660-5. PMID 19060208 DOI: 10.1073/Pnas.0807752105 |
0.333 |
|
| 2008 |
Medici D, Razzaque MS, Deluca S, Rector TL, Hou B, Kang K, Goetz R, Mohammadi M, Kuro-O M, Olsen BR, Lanske B. FGF-23-Klotho signaling stimulates proliferation and prevents vitamin D-induced apoptosis. The Journal of Cell Biology. 182: 459-65. PMID 18678710 DOI: 10.1083/Jcb.200803024 |
0.414 |
|
| 2008 |
Falardeau J, Chung WCJ, Beenken A, Raivio T, Plummer L, Sidis Y, Jacobson-Dickman EE, Eliseenkova AV, Ma J, Dwyer A, Quinton R, Na S, Hall JE, Huot C, Alois N, ... ... Mohammadi M, et al. Decreased FGF8 signaling causes deficiency of gonadotropin-releasing hormone in humans and mice Journal of Clinical Investigation. 118: 2822-2831. PMID 18596921 DOI: 10.1172/Jci34538 |
0.773 |
|
| 2008 |
Inagaki T, Lin VY, Goetz R, Mohammadi M, Mangelsdorf DJ, Kliewer SA. Inhibition of growth hormone signaling by the fasting-induced hormone FGF21. Cell Metabolism. 8: 77-83. PMID 18585098 DOI: 10.1016/J.Cmet.2008.05.006 |
0.44 |
|
| 2008 |
Abdel-Rahman WM, Kalinina J, Shoman S, Eissa S, Ollikainen M, Elomaa O, Eliseenkova AV, Bützow R, Mohammadi M, Peltomäki P. Somatic FGF9 mutations in colorectal and endometrial carcinomas associated with membranous beta-catenin. Human Mutation. 29: 390-7. PMID 18165946 DOI: 10.1002/Humu.20653 |
0.798 |
|
| 2008 |
Abdel-Rahman W, Kalinina J, Eliseenkova A, Eissa S, Ollikainen M, Elomaa O, Bützow R, Shoman S, Mohammadi M, Peltomäki P. FGF9 mutations in colorectal and endometrial cancers European Journal of Cancer Supplements. 6: 48. DOI: 10.1016/S1359-6349(08)71357-0 |
0.759 |
|
| 2007 |
Ben-Dov IZ, Galitzer H, Lavi-Moshayoff V, Goetz R, Kuro-o M, Mohammadi M, Sirkis R, Naveh-Many T, Silver J. The parathyroid is a target organ for FGF23 in rats. The Journal of Clinical Investigation. 117: 4003-8. PMID 17992255 DOI: 10.1172/Jci32409 |
0.446 |
|
| 2007 |
Chen H, Ma J, Li W, Eliseenkova AV, Xu C, Neubert TA, Miller WT, Mohammadi M. A molecular brake in the kinase hinge region regulates the activity of receptor tyrosine kinases. Molecular Cell. 27: 717-30. PMID 17803937 DOI: 10.1016/J.Molcel.2007.06.028 |
0.393 |
|
| 2007 |
Ichikawa S, Imel EA, Kreiter ML, Yu X, Mackenzie DS, Sorenson AH, Goetz R, Mohammadi M, White KE, Econs MJ. A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis. The Journal of Clinical Investigation. 117: 2684-91. PMID 17710231 DOI: 10.1172/Jci31330 |
0.489 |
|
| 2007 |
Kurosu H, Choi M, Ogawa Y, Dickson AS, Goetz R, Eliseenkova AV, Mohammadi M, Rosenblatt KP, Kliewer SA, Kuro-o M. Tissue-specific expression of betaKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21. The Journal of Biological Chemistry. 282: 26687-95. PMID 17623664 DOI: 10.1074/Jbc.M704165200 |
0.55 |
|
| 2007 |
Inagaki T, Dutchak P, Zhao G, Ding X, Gautron L, Parameswara V, Li Y, Goetz R, Mohammadi M, Esser V, Elmquist JK, Gerard RD, Burgess SC, Hammer RE, Mangelsdorf DJ, et al. Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21. Cell Metabolism. 5: 415-25. PMID 17550777 DOI: 10.1016/J.Cmet.2007.05.003 |
0.453 |
|
| 2007 |
Pollock PM, Gartside MG, Dejeza LC, Powell MA, Mallon MA, Davies H, Mohammadi M, Futreal PA, Stratton MR, Trent JM, Goodfellow PJ. Frequent activating FGFR2 mutations in endometrial carcinomas parallel germline mutations associated with craniosynostosis and skeletal dysplasia syndromes. Oncogene. 26: 7158-62. PMID 17525745 DOI: 10.1038/Sj.Onc.1210529 |
0.367 |
|
| 2007 |
Ogawa Y, Kurosu H, Yamamoto M, Nandi A, Rosenblatt KP, Goetz R, Eliseenkova AV, Mohammadi M, Kuro-o M. BetaKlotho is required for metabolic activity of fibroblast growth factor 21. Proceedings of the National Academy of Sciences of the United States of America. 104: 7432-7. PMID 17452648 DOI: 10.1073/Pnas.0701600104 |
0.499 |
|
| 2007 |
Riley BM, Mansilla MA, Ma J, Daack-Hirsch S, Maher BS, Raffensperger LM, Russo ET, Vieira AR, Dodé C, Mohammadi M, Marazita ML, Murray JC. Impaired FGF signaling contributes to cleft lip and palate. Proceedings of the National Academy of Sciences of the United States of America. 104: 4512-7. PMID 17360555 DOI: 10.1073/Pnas.0607956104 |
0.551 |
|
| 2007 |
Goetz R, Beenken A, Ibrahimi OA, Kalinina J, Olsen SK, Eliseenkova AV, Xu C, Neubert TA, Zhang F, Linhardt RJ, Yu X, White KE, Inagaki T, Kliewer SA, Yamamoto M, ... ... Mohammadi M, et al. Molecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members. Molecular and Cellular Biology. 27: 3417-28. PMID 17339340 DOI: 10.1128/Mcb.02249-06 |
0.812 |
|
| 2007 |
Pitteloud N, Quinton R, Pearce S, Raivio T, Acierno J, Dwyer A, Plummer L, Hughes V, Seminara S, Cheng YZ, Li WP, Maccoll G, Eliseenkova AV, Olsen SK, Ibrahimi OA, ... ... Mohammadi M, et al. Digenic mutations account for variable phenotypes in idiopathic hypogonadotropic hypogonadism Journal of Clinical Investigation. 117: 457-463. PMID 17235395 DOI: 10.1172/Jci29884 |
0.767 |
|
| 2006 |
Beenken A, Mohammadi M. Hedgehogs like it sweet, too. Proceedings of the National Academy of Sciences of the United States of America. 103: 17069-70. PMID 17088529 DOI: 10.1073/Pnas.0608456103 |
0.736 |
|
| 2006 |
Pitteloud N, Meysing A, Quinton R, Acierno JS, Dwyer AA, Plummer L, Fliers E, Boepple P, Hayes F, Seminara S, Hughes VA, Ma J, Bouloux P, Mohammadi M, Crowley WF. Mutations in fibroblast growth factor receptor 1 cause Kallmann syndrome with a wide spectrum of reproductive phenotypes. Molecular and Cellular Endocrinology. 254: 60-9. PMID 16764984 DOI: 10.1016/J.Mce.2006.04.021 |
0.393 |
|
| 2006 |
Pitteloud N, Acierno JS, Meysing A, Eliseenkova AV, Ma J, Ibrahimi OA, Metzger DL, Hayes FJ, Dwyer AA, Hughes VA, Yialamas M, Hall JE, Grant E, Mohammadi M, Crowley WF. Mutations in fibroblast growth factor receptor 1 cause both Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism. Proceedings of the National Academy of Sciences of the United States of America. 103: 6281-6. PMID 16606836 DOI: 10.1073/Pnas.0600962103 |
0.691 |
|
| 2006 |
Zhang X, Ibrahimi OA, Olsen SK, Umemori H, Mohammadi M, Ornitz DM. Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family. The Journal of Biological Chemistry. 281: 15694-700. PMID 16597617 DOI: 10.1074/Jbc.M601252200 |
0.832 |
|
| 2006 |
Olsen SK, Li JY, Bromleigh C, Eliseenkova AV, Ibrahimi OA, Lao Z, Zhang F, Linhardt RJ, Joyner AL, Mohammadi M. Structural basis by which alternative splicing modulates the organizer activity of FGF8 in the brain. Genes & Development. 20: 185-98. PMID 16384934 DOI: 10.1101/Gad.1365406 |
0.837 |
|
| 2006 |
Meyer RD, Mohammadi M, Rahimi N. A single amino acid substitution in the activation loop defines the decoy characteristic of VEGFR-1/FLT-1. The Journal of Biological Chemistry. 281: 867-75. PMID 16286478 DOI: 10.1074/Jbc.M506454200 |
0.398 |
|
| 2006 |
Pollock P, Gartside M, Ibrahimi O, Curtis A, Yudt L, Curtin J, Mann G, Bastian B, Meltzer P, Mohammadi M. Functional characterization of FGFR2 mutations in melanoma reveals multiple mechanisms of inactivation Melanoma Research. 16: S97. DOI: 10.1097/00008390-200609001-00178 |
0.631 |
|
| 2005 |
Mohammadi M, Olsen SK, Goetz R. A protein canyon in the FGF-FGF receptor dimer selects from an à la carte menu of heparan sulfate motifs. Current Opinion in Structural Biology. 15: 506-16. PMID 16154740 DOI: 10.1016/J.Sbi.2005.09.002 |
0.763 |
|
| 2005 |
Yu X, Ibrahimi OA, Goetz R, Zhang F, Davis SI, Garringer HJ, Linhardt RJ, Ornitz DM, Mohammadi M, White KE. Analysis of the biochemical mechanisms for the endocrine actions of fibroblast growth factor-23. Endocrinology. 146: 4647-56. PMID 16081635 DOI: 10.1210/En.2005-0670 |
0.765 |
|
| 2005 |
Mohammadi M, Olsen SK, Ibrahimi OA. Structural basis for fibroblast growth factor receptor activation. Cytokine & Growth Factor Reviews. 16: 107-37. PMID 15863029 DOI: 10.1016/J.Cytogfr.2005.01.008 |
0.846 |
|
| 2005 |
Ibrahimi OA, Yeh BK, Eliseenkova AV, Zhang F, Olsen SK, Igarashi M, Aaronson SA, Linhardt RJ, Mohammadi M. Analysis of mutations in fibroblast growth factor (FGF) and a pathogenic mutation in FGF receptor (FGFR) provides direct evidence for the symmetric two-end model for FGFR dimerization. Molecular and Cellular Biology. 25: 671-84. PMID 15632068 DOI: 10.1128/Mcb.25.2.671-684.2005 |
0.831 |
|
| 2005 |
Ibrahimi OA, Chiu ES, McCarthy JG, Mohammadi M. Understanding the molecular basis of Apert syndrome. Plastic and Reconstructive Surgery. 115: 264-70. PMID 15622262 DOI: 10.1097/01.Prs.0000146703.08958.95 |
0.643 |
|
| 2004 |
Ibrahimi OA, Zhang F, Eliseenkova AV, Itoh N, Linhardt RJ, Mohammadi M. Biochemical analysis of pathogenic ligand-dependent FGFR2 mutations suggests distinct pathophysiological mechanisms for craniofacial and limb abnormalities. Human Molecular Genetics. 13: 2313-24. PMID 15282208 DOI: 10.1093/Hmg/Ddh235 |
0.733 |
|
| 2004 |
Ibrahimi OA, Zhang F, Hrstka SC, Mohammadi M, Linhardt RJ. Kinetic model for FGF, FGFR, and proteoglycan signal transduction complex assembly. Biochemistry. 43: 4724-30. PMID 15096041 DOI: 10.1021/Bi0352320 |
0.76 |
|
| 2004 |
Olsen SK, Ibrahimi OA, Raucci A, Zhang F, Eliseenkova AV, Yayon A, Basilico C, Linhardt RJ, Schlessinger J, Mohammadi M. Insights into the molecular basis for fibroblast growth factor receptor autoinhibition and ligand-binding promiscuity. Proceedings of the National Academy of Sciences of the United States of America. 101: 935-40. PMID 14732692 DOI: 10.1073/Pnas.0307287101 |
0.811 |
|
| 2004 |
Ibrahimi OA, Zhang F, Eliseenkova AV, Linhardt RJ, Mohammadi M. Proline to arginine mutations in FGF receptors 1 and 3 result in Pfeiffer and Muenke craniosynostosis syndromes through enhancement of FGF binding affinity. Human Molecular Genetics. 13: 69-78. PMID 14613973 DOI: 10.1093/Hmg/Ddh011 |
0.765 |
|
| 2003 |
Sher I, Yeh BK, Mohammadi M, Adir N, Ron D. Structure-based mutational analyses in FGF7 identify new residues involved in specific interaction with FGFR2IIIb. Febs Letters. 552: 150-4. PMID 14527678 DOI: 10.1016/S0014-5793(03)00909-8 |
0.6 |
|
| 2003 |
Olsen SK, Garbi M, Zampieri N, Eliseenkova AV, Ornitz DM, Goldfarb M, Mohammadi M. Fibroblast growth factor (FGF) homologous factors share structural but not functional homology with FGFs. The Journal of Biological Chemistry. 278: 34226-36. PMID 12815063 DOI: 10.1074/Jbc.M303183200 |
0.76 |
|
| 2003 |
Yeh BK, Igarashi M, Eliseenkova AV, Plotnikov AN, Sher I, Ron D, Aaronson SA, Mohammadi M. Structural basis by which alternative splicing confers specificity in fibroblast growth factor receptors. Proceedings of the National Academy of Sciences of the United States of America. 100: 2266-71. PMID 12591959 DOI: 10.1073/Pnas.0436500100 |
0.589 |
|
| 2002 |
Yeh BK, Eliseenkova AV, Plotnikov AN, Green D, Pinnell J, Polat T, Gritli-Linde A, Linhardt RJ, Mohammadi M. Structural basis for activation of fibroblast growth factor signaling by sucrose octasulfate. Molecular and Cellular Biology. 22: 7184-92. PMID 12242295 DOI: 10.1128/Mcb.22.20.7184-7192.2002 |
0.591 |
|
| 2002 |
Polat T, Mohammadi M, Linhardt RJ. Synthesis of sulfosucrose derivatives for evaluation as regulators of fibroblast growth factor activity Tetrahedron Letters. 43: 8047-8049. DOI: 10.1016/S0040-4039(02)01969-X |
0.367 |
|
| 2001 |
Bellosta P, Iwahori A, Plotnikov AN, Eliseenkova AV, Basilico C, Mohammadi M. Identification of receptor and heparin binding sites in fibroblast growth factor 4 by structure-based mutagenesis. Molecular and Cellular Biology. 21: 5946-57. PMID 11486033 DOI: 10.1128/Mcb.21.17.5946-5957.2001 |
0.633 |
|
| 2001 |
Ibrahimi OA, Eliseenkova AV, Plotnikov AN, Yu K, Ornitz DM, Mohammadi M. Structural basis for fibroblast growth factor receptor 2 activation in Apert syndrome. Proceedings of the National Academy of Sciences of the United States of America. 98: 7182-7. PMID 11390973 DOI: 10.1073/Pnas.121183798 |
0.787 |
|
| 2001 |
Plotnikov AN, Eliseenkova AV, Ibrahimi OA, Shriver Z, Sasisekharan R, Lemmon MA, Mohammadi M. Crystal structure of fibroblast growth factor 9 reveals regions implicated in dimerization and autoinhibition. The Journal of Biological Chemistry. 276: 4322-9. PMID 11060292 DOI: 10.1074/Jbc.M006502200 |
0.767 |
|
| 2000 |
Schlessinger J, Plotnikov AN, Ibrahimi OA, Eliseenkova AV, Yeh BK, Yayon A, Linhardt RJ, Mohammadi M. Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization. Molecular Cell. 6: 743-50. PMID 11030354 DOI: 10.1016/S1097-2765(00)00073-3 |
0.751 |
|
| 2000 |
Plotnikov AN, Hubbard SR, Schlessinger J, Mohammadi M. Crystal structures of two FGF-FGFR complexes reveal the determinants of ligand-receptor specificity. Cell. 101: 413-24. PMID 10830168 DOI: 10.1016/S0092-8674(00)80851-X |
0.56 |
|
| 1999 |
Plotnikov AN, Schlessinger J, Hubbard SR, Mohammadi M. Structural basis for FGF receptor dimerization and activation. Cell. 98: 641-50. PMID 10490103 DOI: 10.1016/S0092-8674(00)80051-3 |
0.496 |
|
| 1999 |
Dell’Era P, Mohammadi M, Presta M. Different Tyrosine Autophosphorylation Requirements in Fibroblast Growth Factor Receptor-1 Mediate Urokinase-Type Plasminogen Activator Induction and Mitogenesis Molecular Biology of the Cell. 10: 23-33. PMID 9880324 DOI: 10.1091/Mbc.10.1.23 |
0.436 |
|
| 1998 |
Mohammadi M, Froum S, Hamby JM, Schroeder MC, Panek RL, Lu GH, Eliseenkova AV, Green D, Schlessinger J, Hubbard SR. Crystal structure of an angiogenesis inhibitor bound to the FGF receptor tyrosine kinase domain. The Embo Journal. 17: 5896-904. PMID 9774334 DOI: 10.1093/Emboj/17.20.5896 |
0.423 |
|
| 1997 |
Mohammadi M, McMahon G, Sun L, Tang C, Hirth P, Yeh BK, Hubbard SR, Schlessinger J. Structures of the tyrosine kinase domain of fibroblast growth factor receptor in complex with inhibitors. Science (New York, N.Y.). 276: 955-60. PMID 9139660 DOI: 10.1126/Science.276.5314.955 |
0.416 |
|
| 1996 |
Roghani M, Mohammadi M, Schlessinger J, Moscatelli D. Induction of urokinase-type plasminogen activator by fibroblast growth factor (FGF)-2 is dependent on expression of FGF receptors and does not require activation of phospholipase Cgamma1. The Journal of Biological Chemistry. 271: 31154-9. PMID 8940113 DOI: 10.1074/Jbc.271.49.31154 |
0.548 |
|
| 1996 |
Mohammadi M, Schlessinger J, Hubbard SR. Structure of the FGF receptor tyrosine kinase domain reveals a novel autoinhibitory mechanism. Cell. 86: 577-87. PMID 8752212 DOI: 10.1016/S0092-8674(00)80131-2 |
0.48 |
|
| 1996 |
Mohammadi M, Dikic I, Sorokin A, Burgess WH, Jaye M, Schlessinger J. Identification of six novel autophosphorylation sites on fibroblast growth factor receptor 1 and elucidation of their importance in receptor activation and signal transduction. Molecular and Cellular Biology. 16: 977-89. PMID 8622701 DOI: 10.1128/Mcb.16.3.977 |
0.445 |
|
| 1995 |
Songyang Z, Carraway KL, Eck MJ, Harrison SC, Feldman RA, Mohammadi M, Schlessinger J, Hubbard SR, Smith DP, Eng C. Catalytic specificity of protein-tyrosine kinases is critical for selective signalling. Nature. 373: 536-9. PMID 7845468 DOI: 10.1038/373536A0 |
0.317 |
|
| 1995 |
Huang J, Mohammadi M, Rodrigues GA, Schlessinger J. Reduced activation of RAF-1 and MAP kinase by a fibroblast growth factor receptor mutant deficient in stimulation of phosphatidylinositol hydrolysis. The Journal of Biological Chemistry. 270: 5065-72. PMID 7534287 DOI: 10.1074/Jbc.270.10.5065 |
0.39 |
|
| 1993 |
Mohammadi M, Honegger A, Sorokin A, Ullrich A, Schlessinger J, Hurwitz DR. Aggregation-induced activation of the epidermal growth factor receptor protein tyrosine kinase. Biochemistry. 32: 8742-8. PMID 8395880 DOI: 10.1021/Bi00085A004 |
0.403 |
|
| 1993 |
Skolnik EY, Batzer A, Li N, Lee CH, Lowenstein E, Mohammadi M, Margolis B, Schlessinger J. The function of GRB2 in linking the insulin receptor to Ras signaling pathways. Science (New York, N.Y.). 260: 1953-5. PMID 8316835 DOI: 10.1126/Science.8316835 |
0.359 |
|
| 1992 |
Rotin D, Margolis B, Mohammadi M, Daly RJ, Daum G, Li N, Fischer EH, Burgess WH, Ullrich A, Schlessinger J. SH2 domains prevent tyrosine dephosphorylation of the EGF receptor: identification of Tyr992 as the high-affinity binding site for SH2 domains of phospholipase C gamma. The Embo Journal. 11: 559-67. PMID 1537335 DOI: 10.1002/J.1460-2075.1992.Tb05087.X |
0.424 |
|
| 1992 |
Mohammadi M, Dionne CA, Li W, Li N, Spivak T, Honegger AM, Jaye M, Schlessinger J. Point mutation in FGF receptor eliminates phosphatidylinositol hydrolysis without affecting mitogenesis. Nature. 358: 681-4. PMID 1379698 DOI: 10.1038/358681A0 |
0.48 |
|
| 1992 |
Schlessinger J, Mohammadi M, Margolis B, Ullrich A. Role of SH2-containing proteins in cellular signaling by receptor tyrosine kinases. Cold Spring Harbor Symposia On Quantitative Biology. 57: 67-74. PMID 1339705 DOI: 10.1101/Sqb.1992.057.01.009 |
0.341 |
|
| 1991 |
Skolnik EY, Margolis B, Mohammadi M, Lowenstein E, Fischer R, Drepps A, Ullrich A, Schlessinger J. Cloning of PI3 kinase-associated p85 utilizing a novel method for expression/cloning of target proteins for receptor tyrosine kinases. Cell. 65: 83-90. PMID 1849461 DOI: 10.1016/0092-8674(91)90410-Z |
0.389 |
|
| 1991 |
Mohammadi M, Honegger AM, Rotin D, Fischer R, Bellot F, Li W, Dionne CA, Jaye M, Rubinstein M, Schlessinger J. A tyrosine-phosphorylated carboxy-terminal peptide of the fibroblast growth factor receptor (Flg) is a binding site for the SH2 domain of phospholipase C-gamma 1. Molecular and Cellular Biology. 11: 5068-78. PMID 1656221 DOI: 10.1128/Mcb.11.10.5068 |
0.439 |
|
| 1990 |
Margolis B, Li N, Koch A, Mohammadi M, Hurwitz DR, Zilberstein A, Ullrich A, Pawson T, Schlessinger J. The tyrosine phosphorylated carboxyterminus of the EGF receptor is a binding site for GAP and PLC-gamma. The Embo Journal. 9: 4375-4380. DOI: 10.1002/J.1460-2075.1990.Tb07887.X |
0.438 |
|
| Show low-probability matches. |